GA NCORP

Treatment Sites

Harbin Clinic Cancer Center

Physical Address:  
255 West 5th Street
Rome, Georgia 30165

Harbin Clinic Radiation Oncology is accredited by the American College of Radiology. Harbin Clinic Medical Oncology is formerly a member of the Atlanta Regional Community Clinical Oncology Program, a program initiated by the National Cancer Institute to provide community hospitals access to a wide range of research studies.Additionally, Harbin Clinic is a member of the Georgia CORE Research Network, a statewide network of academic and community-based oncologists and researchers. The Harbin Clinic is also a recipient of the Georgia Cancer Coalition Distinguished Cancer Scholars Award, which supports leaders who are engaged in the most promising areas of cancer research. Located in Rome, GA, Harbin Clinic has five physicians who specialize in medical and radiation oncology. The Clinic provides the following medical oncology services: cancer treatment, chemotherapy, and treatment of hematologic conditions. Harbin Clinic Radiation Oncology offers Northwest Georgia cancer patients cutting edge cancer treatment technology including state-of-the-art linear accelerators for Radiation Therapy delivery, access to advanced diagnostic radiologic imaging modalities such as CT, PET/CT and MRI. They also have intensity modulated radiation therapy (IMRT), image guided radiation therapy (IGRT), Stereotactic Radiosurgery (SRS), Stereotactic Body Radiation Therapy (SBRT), Brachytherapy (Internal Radiotherapy), prostate seed implants for localized prostate cancer, Mammosite for early stages of breast cancer, and integrative oncology which combines evidence based complementary and alternative medicine with conventional medical therapies to create individualized plans to treat the whole person.

Treatment Sites


Primary Location

255 West Fifth Street
Rome, GA 30165
706-528-9110 (p)
706-528-9111 (f)
www.harbinclinic.com

driving directions

Clinical Trials

Genetic Testing in Screening Patients with Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)
Cancer Type: Lung Cancer
Study Coordinator: Terri Brannon - 706-528-9094


Nivolumab and Ipilimumab in Treating Patients with Rare Tumors
Cancer Type: Adrenal Cancer, Bile Duct Cancer, Bladder Cancer, Bone Tumor, Brain Tumor, Cervical Cancer, Colon/Rectal Cancer, Esophogeal Cancer, Gallbladder Cancer, Gastrointestinal Stromal Tumor (GIST), Germ Cell Tumor, Gestational trophoblastic disease, Gynecologic Cancers, Head and Neck Cancer, Liver Cancer / Hepatoblastoma, Lung Cancer, Mesothelioma, Neuroendocrine Tumor, Ovarian Cancer, Parathyroid Cancer, Penile Cancer, Retroperitoneal Tumors, Sarcoma, Small Bowel Cancer, Solid Tumor, Stomach/ Gastric Cancer, Testicular Cancer, Thyroid Cancer, Unknown Primary, Ureter Cancer, Urethral Cancer

Targeted Therapy Directed by Genetic Testing in Treating Patients with Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Cancer Type: Bladder Cancer, Brain & Spinal Cord Tumor, Breast Cancer, Cervical Cancer, Colon/Rectal Cancer, Esophogeal Cancer, Head and Neck Cancer, Kidney Cancer, Liver Cancer / Hepatoblastoma, Lung Cancer, Lymphoma, Melanoma, Multiple Myeloma, Ovarian Cancer, Pancreatic Cancer, Plasma cell neoplasm, Prostate Cancer , Skin Cancer (Non-Melanoma), Stomach/ Gastric Cancer, Thyroid Cancer, Unknown Primary, Uterine Cancer
Study Coordinator: Terri Brannon - 706-528-9094